Latest

Search ...

FILTER BY TYPE

News & articles

Events

Knowledge Pills

Publications

Multimedia

FILTER BY CATEGORY

course category

Accelerator

Clinical Research

Data Hub

ERDERA

Expertise Services

Funding

International Alignment

Patient Public Involvement and Engagement (PPIE)

Policy and Regulation

Training and Education

ERDERA PUBLICATION

Publication is ERDERA

Yes

SCIENTIFIC PUBLICATION

Publication is Scientific

Yes

FILTER BY TAG

Select some options

Course Tag

(Inter)national capacity alignment

2006

2016

2020

2021

2022

2023

2024

2025

2026

2027

3Rs principles (Replacement Reduction and Refinement)

Aarhus University

Acceleration Hub

Action Plan

Advocacy

AFM Téléthon

AI technologies

Alexandre Hoischen

Alexandre Méjat

Alpe Adria Meeting

Ana Rath

Antisense Oligonucleotide (ASO) Frameworks

Artificial Intelligence (AI)

Assay Development

ataxia

ATMPs (Advanced Therapy Medicinal Products)

Australia

Austria

Balkan Congress of Human Genetics

Başak Uysal

Basket Trials

Batten disease

Bayesian

Belgium

Bethlem myopathy

Biobank

Biomanufacturing

Biomarker

Biotech Act II

Biotechnology

Black Pearl Awards

Bojana Mirosavljević

Bulgaria

Call

Canada

CAR-T cell

Cell therapies

Cell Therapy Medicinal Products (CTMP)

Chan Zuckerberg Initiative (CZI)

Chromatinopathies

Clinical data annotation

Clinical Development

Clinical Research Networks (CRNs)

Clinical Trials

Committee for Medicinal Products for Human Use (CHMP)

CPS1 deficiency

CRISPR

Critical Path Institute (C-PATH)

cross-sectional studies

Cyprus

Czech Republic

Danish National Rehabilitation Center for Neuromuscular Diseases

Daria Julkowska

Data Collection and Sharing

data interoperability

Data Protection

Data science

Data Standardisation

Data Stewardship

Denmark

Diagnosis

Diagnostics

Digital Health

Dilated Cardiomyopathy

Diversity and Inclusion (EDI)

DNA

Dorica Dan

Drug Repurposing

Duchenne muscular dystrophy (DMD)

Early Career Researchers

Early Diagnosis

EATRIS

Ectodermal Dysplasia (ED)

EJP RD

Emine Eylül Taşkın

Epidemiology

Epigenetic

Equality

Equity

ERDERA

ERDERA Clinical Trial Call

ERDERA Diagnostic Research Workstream

ERDERA Policy Brief

ERN-EuroBloodNet

ERN-ITHACA

Estonia

Ethics

EU Rare Disease Action Plan

European Clinical Research Infrastructure Network (ECRIN)

European Commission

European Commission’s Health Innovations and Ecosystems Unit (DG RTD)

European Conference on Rare Disease and Orphan Drugs ECRD

European Federation of Pharmaceutical Industries and Associations (EFPIA)

European Genomic Data Infrastructure (GDI)

European Health Data Space

European Medicines Agency (EMA)

European networks

European Parliament

European Partnerships

European Reference Networks (ERNs)

European Society of Human Genetics (ESHG)

European Union

EURORDIS–Rare Diseases Europe

FAIR Principles

Fanny Mochel

Florence Guillot

France

FrBioNet

Gavin Lawler

Gdansk

Gene regulatory aberrations

Gene Therapy

Gene Therapy Medicinal Product (GTMP)

General Assembly Meeting

genetic diagnosis

Genetic diseases

genetic inheritance

Genetic testing

genetic variation

genetics

Genome-Phenome Analysis Platform (GPAP)

Genome/exome reanalysis

Genomic data analysis

Genomic data submission

Genomics

Germany

Good clinical practice (GCP)

Good Manufacturing Practices (CMP)

Greece

Health Policy

Health Research Charities Ireland (HRCI)

Health Technology Assessment (HTA)

High-Level Meeting

Holm Graessner

Human Phenotype Ontology (HPO)

Hungary

Huntington's disease

Iceland

ICORD (International Collaboration on Rare Diseases and Orphan Drugs)

Innovation

Innovative Health Initiative IHI

Institut Imagine

International alignment

International Conference on CRNs

International Rare Diseases Research Consortium (IRDiRC)

Interview

Investment

iPSC

Ireland

Irene Norstedt

Israel

Italy

Item Response Theory

Jamboree

JARDIN Joint Action

Jean Saslawsky

Joint Transnational Call

JTC 2025

Latvia

Lithuania

Living with Rare

Long-read Genome Sequencing

Long-read Sequencing

longitudinal modelling

Luxembourg

Magda Chlebus

Masterclass

Maurizio Scarpa

Medical Devices

Medical University of Gdansk (GUMed)

Medicines Research and Development

MetabERN

Metabolic diseases

Metachromatic leukodystrophy (MLD)

Methodology

model-based approaches

Molecular Diagnosis

Morocco

motor neurons

mRNA

Multi-omics

Multi-omics analysis

Multiomic profiling

N‑of‑1 Genomic Therapies

National Alignment Board

National Mirror Group (NMG)

National Rare Disease Registries

Network Supporting Scheme (NSS)

Neurodevelopmental disorders

Neurological Diseases

Neuromuscular disorders

Neuronal Ceroid Lipofuscinosis (NCL)

New Approach Methodologies (NAMs)

New Zealand

Newborn Screening

Non-human primates (NHPs)

Norway

Open Academy

Open Science

Optical Genome Mapping

Orphan Drugs

Orphanet

Orphanet coding

Paediatric

Pairwise Comparison

Partnership

Patient Advocacy

Patient engagement

Patient Public Involvement and Engagement (PPIE)

Patient registries

Patient voice

Patient-Reported Experience Measures (PREMs)

Patient-Reported Outcome Measures (PROMs)

Personalized medicine

Petia Stratieva

Phage Therapy

Pheno-clinical data

Pluripotent Stem Cell

Poland

Policy Think Tank

Policy to Science

Polyangiitis

Portugal

Prader-Willi Syndrome (PWS)

Pre-Clinical Studies

Precision Medicine

Press Release

Project Management

Project Preparation and Proposal

PROTRIDER

Public-Private Collaboration

Radka Kaneva

Rare Cancers

Rare Disease Center Patient Council at GUMed

Rare Disease Clinical Trial Network (RDCTN)

Rare Disease Cures Accelerator – Data and Analytics Platform (RDCA-DAP)

Rare Disease Day

Rare Disease International (RDI)

Rare Diseases Virtual Platform (VP)

Rare Youth Revolution

RD-Connect GPAP

RE(ACT) Congress

Real World Evidence

Real-World Data (RWD)

RealiseD

Regenerative medicine

Regulatory

REMEDI4ALL

Research and Science

Research Design

Riga

RNA (Ribonucleic Acid)

RNA sequencing

Romania

Ronald Cornet

Roseline Favresse

Sandra Alves

SARA

Science Magazine

Sequencing

Serbia

Serena Scollen

Short tandem repeats

Single‑Arm Trials (SATs)

Slovakia

Slovenia

SMEs (Small and Medium-sized Enterprises)

Solvathon

Solve-RD

Sophie Skoubo

Spain

Stakeholder Forum

State of the Art RD Country Reports

Statistics

Stem Cells

Strategic Research and Innovation Agenda (SRIA)

Surveys and Polls

Sweden

Switzerland

Target validation

Tavneos

TEDDY

The Cyprus Institute of Neurology & Genetics

The Netherlands

Therapies and Treatment

Tissue Engineered Products (TEP)

Together For Rare Diseases (T4RD)

Tomasz Grybek

toolbox

Toolkit

Towards an EU Action Plan on Rare Diseases

Training and Education

transcriptome analysis

Translational Research

Treatment Boards and Case Dossiers

Triplet Repeat Expansion

Truncating variations in the titin gene

Tumor characterization

Türkiye

Ultra-rare diseases

Underrepresented Countries

Undiagnosed Day

Undiagnosed Hackathons

United Kingdom

United Nations

University Clinical Centre (UCK)

University Clinical Centre in Gdansk (UCK)

Vaccines

Variant interpretation

Vicente Yepez

Victoria Hedley

Waskyra

Webinar

Wilhelm Foundation

Wiskott-Aldrich syndrome (WAS)

WODC

Women's Day

Workshop

World Duchenne Organisation

World Health Organization (WHO)

World Orphan Drug Congress

Yanis Mimouni

Young patients

Yvo Roos

Zoya's Law

ERDERA Clinical Trial Call – Model Award Agreement

1 September 2026

Model award agreement document setting out the structure, articles and contractual provisions applicable to funded activities.

ERDERA Clinical Trial Call – Annex IV. Guidelines for Canadian Applicants

1 September 2026

This annex explains the specific eligibility, sponsorship, funding and application requirements for Canadian applicants in the ERDERA Clinical Trial Call.

ERDERA Clinical Trial Call – Call Text

1 September 2026

Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026.

Scientist reading a journal article 2026

Longitudinal progression, metrics, age-dependence, and modifiers of ataxia severity in SCA27B: a multicentre study of 219 patients

18 August 2026

The multicentre observational study analysed 661 assessments from 219 people with SCA27B to examine disease progression, clinical outcome metrics and demographic or genetic modifiers.